Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

How much phenotypic variation can be attributed to parkin genotype?

Identifieur interne : 000E78 ( Main/Corpus ); précédent : 000E77; suivant : 000E79

How much phenotypic variation can be attributed to parkin genotype?

Auteurs : Ebba Lohmann ; Magali Periquet ; Vincenzo Bonifati ; Nick W. Wood ; Giuseppe De Michele ; Anne-Marie Bonnet ; Valérie Fraix ; Emmanuel Broussolle ; Martin W. I. M. Horstink ; Marie Vidailhet ; Patrice Verpillat ; Thomas Gasser ; David Nicholl ; Hélio Teive ; Salmo Raskin ; Olivier Rascol ; Alain Destée ; Merle Ruberg ; Francesca Gasparini ; Giuseppe Meco ; Yves Agid ; Alexandra Durr ; Alexis Brice

Source :

RBID : ISTEX:8102A84AE65564CFF96B0DCEDB6A81510425F787

Abstract

To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without parkin mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the parkin mutation. Age at onset in carriers of parkin mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of parkin resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003

Url:
DOI: 10.1002/ana.10613

Links to Exploration step

ISTEX:8102A84AE65564CFF96B0DCEDB6A81510425F787

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">How much phenotypic variation can be attributed to parkin genotype?</title>
<author>
<name sortKey="Lohmann, Ebba" sort="Lohmann, Ebba" uniqKey="Lohmann E" first="Ebba" last="Lohmann">Ebba Lohmann</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Periquet, Magali" sort="Periquet, Magali" uniqKey="Periquet M" first="Magali" last="Periquet">Magali Periquet</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonifati, Vincenzo" sort="Bonifati, Vincenzo" uniqKey="Bonifati V" first="Vincenzo" last="Bonifati">Vincenzo Bonifati</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nick W" sort="Wood, Nick W" uniqKey="Wood N" first="Nick W." last="Wood">Nick W. Wood</name>
<affiliation>
<mods:affiliation>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Michele, Giuseppe" sort="De Michele, Giuseppe" uniqKey="De Michele G" first="Giuseppe" last="De Michele">Giuseppe De Michele</name>
<affiliation>
<mods:affiliation>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonnet, Anne Arie" sort="Bonnet, Anne Arie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fraix, Valerie" sort="Fraix, Valerie" uniqKey="Fraix V" first="Valérie" last="Fraix">Valérie Fraix</name>
<affiliation>
<mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Broussolle, Emmanuel" sort="Broussolle, Emmanuel" uniqKey="Broussolle E" first="Emmanuel" last="Broussolle">Emmanuel Broussolle</name>
<affiliation>
<mods:affiliation>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Horstink, Martin W I M" sort="Horstink, Martin W I M" uniqKey="Horstink M" first="Martin W. I. M." last="Horstink">Martin W. I. M. Horstink</name>
<affiliation>
<mods:affiliation>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Service de Neurologie, Hôpital Saint Antoine, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Verpillat, Patrice" sort="Verpillat, Patrice" uniqKey="Verpillat P" first="Patrice" last="Verpillat">Patrice Verpillat</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gasser, Thomas" sort="Gasser, Thomas" uniqKey="Gasser T" first="Thomas" last="Gasser">Thomas Gasser</name>
<affiliation>
<mods:affiliation>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nicholl, David" sort="Nicholl, David" uniqKey="Nicholl D" first="David" last="Nicholl">David Nicholl</name>
<affiliation>
<mods:affiliation>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teive, Helio" sort="Teive, Helio" uniqKey="Teive H" first="Hélio" last="Teive">Hélio Teive</name>
<affiliation>
<mods:affiliation>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Raskin, Salmo" sort="Raskin, Salmo" uniqKey="Raskin S" first="Salmo" last="Raskin">Salmo Raskin</name>
<affiliation>
<mods:affiliation>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<mods:affiliation>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation>
<mods:affiliation>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gasparini, Francesca" sort="Gasparini, Francesca" uniqKey="Gasparini F" first="Francesca" last="Gasparini">Francesca Gasparini</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meco, Giuseppe" sort="Meco, Giuseppe" uniqKey="Meco G" first="Giuseppe" last="Meco">Giuseppe Meco</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Durr">Alexandra Durr</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8102A84AE65564CFF96B0DCEDB6A81510425F787</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/ana.10613</idno>
<idno type="url">https://api.istex.fr/document/8102A84AE65564CFF96B0DCEDB6A81510425F787/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000E78</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">How much phenotypic variation can be attributed to parkin genotype?</title>
<author>
<name sortKey="Lohmann, Ebba" sort="Lohmann, Ebba" uniqKey="Lohmann E" first="Ebba" last="Lohmann">Ebba Lohmann</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Periquet, Magali" sort="Periquet, Magali" uniqKey="Periquet M" first="Magali" last="Periquet">Magali Periquet</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonifati, Vincenzo" sort="Bonifati, Vincenzo" uniqKey="Bonifati V" first="Vincenzo" last="Bonifati">Vincenzo Bonifati</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Wood, Nick W" sort="Wood, Nick W" uniqKey="Wood N" first="Nick W." last="Wood">Nick W. Wood</name>
<affiliation>
<mods:affiliation>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Michele, Giuseppe" sort="De Michele, Giuseppe" uniqKey="De Michele G" first="Giuseppe" last="De Michele">Giuseppe De Michele</name>
<affiliation>
<mods:affiliation>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bonnet, Anne Arie" sort="Bonnet, Anne Arie" uniqKey="Bonnet A" first="Anne-Marie" last="Bonnet">Anne-Marie Bonnet</name>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Fraix, Valerie" sort="Fraix, Valerie" uniqKey="Fraix V" first="Valérie" last="Fraix">Valérie Fraix</name>
<affiliation>
<mods:affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Broussolle, Emmanuel" sort="Broussolle, Emmanuel" uniqKey="Broussolle E" first="Emmanuel" last="Broussolle">Emmanuel Broussolle</name>
<affiliation>
<mods:affiliation>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Horstink, Martin W I M" sort="Horstink, Martin W I M" uniqKey="Horstink M" first="Martin W. I. M." last="Horstink">Martin W. I. M. Horstink</name>
<affiliation>
<mods:affiliation>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Service de Neurologie, Hôpital Saint Antoine, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Verpillat, Patrice" sort="Verpillat, Patrice" uniqKey="Verpillat P" first="Patrice" last="Verpillat">Patrice Verpillat</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gasser, Thomas" sort="Gasser, Thomas" uniqKey="Gasser T" first="Thomas" last="Gasser">Thomas Gasser</name>
<affiliation>
<mods:affiliation>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nicholl, David" sort="Nicholl, David" uniqKey="Nicholl D" first="David" last="Nicholl">David Nicholl</name>
<affiliation>
<mods:affiliation>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teive, Helio" sort="Teive, Helio" uniqKey="Teive H" first="Hélio" last="Teive">Hélio Teive</name>
<affiliation>
<mods:affiliation>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Raskin, Salmo" sort="Raskin, Salmo" uniqKey="Raskin S" first="Salmo" last="Raskin">Salmo Raskin</name>
<affiliation>
<mods:affiliation>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation>
<mods:affiliation>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Destee, Alain" sort="Destee, Alain" uniqKey="Destee A" first="Alain" last="Destée">Alain Destée</name>
<affiliation>
<mods:affiliation>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberg, Merle" sort="Ruberg, Merle" uniqKey="Ruberg M" first="Merle" last="Ruberg">Merle Ruberg</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gasparini, Francesca" sort="Gasparini, Francesca" uniqKey="Gasparini F" first="Francesca" last="Gasparini">Francesca Gasparini</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meco, Giuseppe" sort="Meco, Giuseppe" uniqKey="Meco G" first="Giuseppe" last="Meco">Giuseppe Meco</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Durr">Alexandra Durr</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brice, Alexis" sort="Brice, Alexis" uniqKey="Brice A" first="Alexis" last="Brice">Alexis Brice</name>
<affiliation>
<mods:affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of Neurology</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="ISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-08">2003-08</date>
<biblScope unit="volume">54</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="176">176</biblScope>
<biblScope unit="page" to="185">185</biblScope>
</imprint>
<idno type="ISSN">0364-5134</idno>
</series>
<idno type="istex">8102A84AE65564CFF96B0DCEDB6A81510425F787</idno>
<idno type="DOI">10.1002/ana.10613</idno>
<idno type="ArticleID">ANA10613</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without parkin mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the parkin mutation. Age at onset in carriers of parkin mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of parkin resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Ebba Lohmann MD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Magali Periquet BS</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Vincenzo Bonifati MD</name>
<affiliations>
<json:string>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>Nick W. Wood MD, PhD, FRCP</name>
<affiliations>
<json:string>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>Giuseppe De Michele MD</name>
<affiliations>
<json:string>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>Anne‐Marie Bonnet MD</name>
<affiliations>
<json:string>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</json:string>
</affiliations>
</json:item>
<json:item>
<name>Valérie Fraix MD</name>
<affiliations>
<json:string>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Emmanuel Broussolle MD</name>
<affiliations>
<json:string>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Martin W. I. M. Horstink MD</name>
<affiliations>
<json:string>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>Marie Vidailhet MD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
<json:string>Service de Neurologie, Hôpital Saint Antoine, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Patrice Verpillat MD, PhD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
<json:string>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Thomas Gasser MD</name>
<affiliations>
<json:string>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>David Nicholl MRCP</name>
<affiliations>
<json:string>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>Hélio Teive MD</name>
<affiliations>
<json:string>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</json:string>
</affiliations>
</json:item>
<json:item>
<name>Salmo Raskin MD</name>
<affiliations>
<json:string>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</json:string>
</affiliations>
</json:item>
<json:item>
<name>Olivier Rascol MD, PhD</name>
<affiliations>
<json:string>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alain Destée MD</name>
<affiliations>
<json:string>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Merle Ruberg MD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Francesca Gasparini MD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Giuseppe Meco MD</name>
<affiliations>
<json:string>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yves Agid MD, PhD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
<json:string>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alexandra Durr MD, PhD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
<json:string>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Alexis Brice MD</name>
<affiliations>
<json:string>INSERM U289, Hôpital de la Salpêtrière, Paris, France</json:string>
<json:string>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</json:string>
<json:string>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>ANA10613</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without parkin mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the parkin mutation. Age at onset in carriers of parkin mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of parkin resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003</abstract>
<qualityIndicators>
<score>7.448</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 801 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>0</keywordCount>
<abstractCharCount>1391</abstractCharCount>
<pdfWordCount>6532</pdfWordCount>
<pdfCharCount>41053</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>204</abstractWordCount>
</qualityIndicators>
<title>How much phenotypic variation can be attributed to parkin genotype?</title>
<corporate>
<json:item>
<name>The French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease</name>
</json:item>
</corporate>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>54</volume>
<publisherId>
<json:string>ANA</json:string>
</publisherId>
<pages>
<total>10</total>
<last>185</last>
<first>176</first>
</pages>
<issn>
<json:string>0364-5134</json:string>
</issn>
<issue>2</issue>
<subject>
<json:item>
<value>Original Articles</value>
</json:item>
</subject>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8249</json:string>
</eissn>
<title>Annals of Neurology</title>
<doi>
<json:string>10.1002/(ISSN)1531-8249</json:string>
</doi>
</host>
<publicationDate>2003</publicationDate>
<copyrightDate>2003</copyrightDate>
<doi>
<json:string>10.1002/ana.10613</json:string>
</doi>
<id>8102A84AE65564CFF96B0DCEDB6A81510425F787</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/8102A84AE65564CFF96B0DCEDB6A81510425F787/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/8102A84AE65564CFF96B0DCEDB6A81510425F787/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/8102A84AE65564CFF96B0DCEDB6A81510425F787/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">How much phenotypic variation can be attributed to parkin genotype?</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2003</date>
</publicationStmt>
<notesStmt>
<note>Association France‐Parkinson</note>
<note>European Community Biomed 2 - No. BMHCT960664;</note>
<note>AVENTIS‐PHARMA</note>
<note>National Institute of Health - No. NS41723‐01A1;</note>
<note>INSERM and Ministère de la Recherche - No. 4CH03G;</note>
<note>Italian Ministry for University and Scientific and Technological Research</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">How much phenotypic variation can be attributed to parkin genotype?</title>
<author>
<orgName>The French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease</orgName>
</author>
<author>
<persName>
<forename type="first">Ebba</forename>
<surname>Lohmann</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Magali</forename>
<surname>Periquet</surname>
</persName>
<roleName type="degree">BS</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Vincenzo</forename>
<surname>Bonifati</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</affiliation>
</author>
<author>
<persName>
<forename type="first">Nick W.</forename>
<surname>Wood</surname>
</persName>
<roleName type="degree">MD, PhD, FRCP</roleName>
<affiliation>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</affiliation>
</author>
<author>
<persName>
<forename type="first">Giuseppe</forename>
<surname>De Michele</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</affiliation>
</author>
<author>
<persName>
<forename type="first">Anne‐Marie</forename>
<surname>Bonnet</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
</author>
<author>
<persName>
<forename type="first">Valérie</forename>
<surname>Fraix</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Emmanuel</forename>
<surname>Broussolle</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Martin W. I. M.</forename>
<surname>Horstink</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</affiliation>
</author>
<author>
<persName>
<forename type="first">Marie</forename>
<surname>Vidailhet</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Service de Neurologie, Hôpital Saint Antoine, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Patrice</forename>
<surname>Verpillat</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Thomas</forename>
<surname>Gasser</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">David</forename>
<surname>Nicholl</surname>
</persName>
<roleName type="degree">MRCP</roleName>
<affiliation>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</affiliation>
</author>
<author>
<persName>
<forename type="first">Hélio</forename>
<surname>Teive</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</affiliation>
</author>
<author>
<persName>
<forename type="first">Salmo</forename>
<surname>Raskin</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</affiliation>
</author>
<author>
<persName>
<forename type="first">Olivier</forename>
<surname>Rascol</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</affiliation>
</author>
<author>
<persName>
<forename type="first">Alain</forename>
<surname>Destée</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Merle</forename>
<surname>Ruberg</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Francesca</forename>
<surname>Gasparini</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Giuseppe</forename>
<surname>Meco</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</affiliation>
</author>
<author>
<persName>
<forename type="first">Yves</forename>
<surname>Agid</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
</author>
<author>
<persName>
<forename type="first">Alexandra</forename>
<surname>Durr</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">Alexis</forename>
<surname>Brice</surname>
</persName>
<roleName type="degree">MD</roleName>
<note type="correspondence">
<p>Correspondence: INSERM U289, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France</p>
</note>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
<affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Annals of Neurology</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="pISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<idno type="DOI">10.1002/(ISSN)1531-8249</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-08"></date>
<biblScope unit="volume">54</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="176">176</biblScope>
<biblScope unit="page" to="185">185</biblScope>
</imprint>
</monogr>
<idno type="istex">8102A84AE65564CFF96B0DCEDB6A81510425F787</idno>
<idno type="DOI">10.1002/ana.10613</idno>
<idno type="ArticleID">ANA10613</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2003</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without parkin mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the parkin mutation. Age at onset in carriers of parkin mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of parkin resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003</p>
</abstract>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article category</head>
<item>
<term>Original Articles</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2002-11-22">Received</change>
<change when="2003-04-01">Registration</change>
<change when="2003-08">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/8102A84AE65564CFF96B0DCEDB6A81510425F787/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8249</doi>
<issn type="print">0364-5134</issn>
<issn type="electronic">1531-8249</issn>
<idGroup>
<id type="product" value="ANA"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="ANNALS OF NEUROLOGY">Annals of Neurology</title>
<title type="short">Ann Neurol.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="20">
<doi origin="wiley" registered="yes">10.1002/ana.v54:2</doi>
<numberingGroup>
<numbering type="journalVolume" number="54">54</numbering>
<numbering type="journalIssue">2</numbering>
</numberingGroup>
<coverDate startDate="2003-08">August 2003</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="8" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/ana.10613</doi>
<idGroup>
<id type="unit" value="ANA10613"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Original Articles</title>
<title type="tocHeading1">Original Articles</title>
</titleGroup>
<copyright ownership="publisher">Copyright © 2003 American Neurological Association</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2002-11-22"></event>
<event type="manuscriptRevised" date="2003-03-07"></event>
<event type="manuscriptAccepted" date="2003-04-01"></event>
<event type="firstOnline" date="2003-05-30"></event>
<event type="publishedOnlineFinalForm" date="2003-07-25"></event>
<event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2003-05-30"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-03"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">176</numbering>
<numbering type="pageLast">185</numbering>
</numberingGroup>
<correspondenceTo>INSERM U289, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France</correspondenceTo>
<objectNameGroup>
<objectName elementName="figure">Illustration</objectName>
<objectName elementName="appendix">APPENDIX</objectName>
</objectNameGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:ANA.ANA10613.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="1"></count>
<count type="tableTotal" number="7"></count>
<count type="referenceTotal" number="60"></count>
<count type="wordTotal" number="7585"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">How much phenotypic variation can be attributed to
<i>parkin</i>
genotype?</title>
<title type="short" xml:lang="en">Phenotypic Variation of
<fi>Parkin</fi>
</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Ebba</givenNames>
<familyName>Lohmann</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Magali</givenNames>
<familyName>Periquet</familyName>
<degrees>BS</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Vincenzo</givenNames>
<familyName>Bonifati</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Nick W.</givenNames>
<familyName>Wood</familyName>
<degrees>MD, PhD, FRCP</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af4">
<personName>
<givenNames>Giuseppe</givenNames>
<familyName>De Michele</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af5">
<personName>
<givenNames>Anne‐Marie</givenNames>
<familyName>Bonnet</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af6">
<personName>
<givenNames>Valérie</givenNames>
<familyName>Fraix</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af7">
<personName>
<givenNames>Emmanuel</givenNames>
<familyName>Broussolle</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au9" creatorRole="author" affiliationRef="#af8">
<personName>
<givenNames>Martin W. I. M.</givenNames>
<familyName>Horstink</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au10" creatorRole="author" affiliationRef="#af1 #af9">
<personName>
<givenNames>Marie</givenNames>
<familyName>Vidailhet</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au11" creatorRole="author" affiliationRef="#af1 #af10">
<personName>
<givenNames>Patrice</givenNames>
<familyName>Verpillat</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au12" creatorRole="author" affiliationRef="#af11">
<personName>
<givenNames>Thomas</givenNames>
<familyName>Gasser</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au13" creatorRole="author" affiliationRef="#af12">
<personName>
<givenNames>David</givenNames>
<familyName>Nicholl</familyName>
<degrees>MRCP</degrees>
</personName>
</creator>
<creator xml:id="au14" creatorRole="author" affiliationRef="#af13">
<personName>
<givenNames>Hélio</givenNames>
<familyName>Teive</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au15" creatorRole="author" affiliationRef="#af14">
<personName>
<givenNames>Salmo</givenNames>
<familyName>Raskin</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au16" creatorRole="author" affiliationRef="#af15">
<personName>
<givenNames>Olivier</givenNames>
<familyName>Rascol</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au17" creatorRole="author" affiliationRef="#af16">
<personName>
<givenNames>Alain</givenNames>
<familyName>Destée</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au18" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Merle</givenNames>
<familyName>Ruberg</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au19" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>Francesca</givenNames>
<familyName>Gasparini</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au20" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Giuseppe</givenNames>
<familyName>Meco</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au21" creatorRole="author" affiliationRef="#af1 #af5">
<personName>
<givenNames>Yves</givenNames>
<familyName>Agid</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au22" creatorRole="author" affiliationRef="#af1 #af17">
<personName>
<givenNames>Alexandra</givenNames>
<familyName>Durr</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au23" creatorRole="author" affiliationRef="#af1 #af5 #af17" corresponding="yes">
<personName>
<givenNames>Alexis</givenNames>
<familyName>Brice</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails>
<email>brice@ccr.jussieu.fr</email>
</contactDetails>
</creator>
<creator xml:id="au24" creatorRole="author" noteRef="#fn1">
<groupName>The French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease</groupName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="IT" type="organization">
<unparsedAffiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="IT" type="organization">
<unparsedAffiliation>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af5" countryCode="FR" type="organization">
<unparsedAffiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af6" countryCode="FR" type="organization">
<unparsedAffiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af7" countryCode="FR" type="organization">
<unparsedAffiliation>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af8" countryCode="NL" type="organization">
<unparsedAffiliation>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af9" countryCode="FR" type="organization">
<unparsedAffiliation>Service de Neurologie, Hôpital Saint Antoine, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af10" countryCode="FR" type="organization">
<unparsedAffiliation>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af11" countryCode="DE" type="organization">
<unparsedAffiliation>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af12" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af13" countryCode="BR" type="organization">
<unparsedAffiliation>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af14" countryCode="BR" type="organization">
<unparsedAffiliation>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af15" countryCode="US" type="organization">
<unparsedAffiliation>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af16" countryCode="FR" type="organization">
<unparsedAffiliation>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af17" countryCode="FR" type="organization">
<unparsedAffiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<fundingInfo>
<fundingAgency>Association France‐Parkinson</fundingAgency>
</fundingInfo>
<fundingInfo>
<fundingAgency>European Community Biomed 2</fundingAgency>
<fundingNumber>BMHCT960664</fundingNumber>
</fundingInfo>
<fundingInfo>
<fundingAgency>AVENTIS‐PHARMA</fundingAgency>
</fundingInfo>
<fundingInfo>
<fundingAgency>National Institute of Health</fundingAgency>
<fundingNumber>NS41723‐01A1</fundingNumber>
</fundingInfo>
<fundingInfo>
<fundingAgency>INSERM and Ministère de la Recherche</fundingAgency>
<fundingNumber>4CH03G</fundingNumber>
</fundingInfo>
<fundingInfo>
<fundingAgency>Italian Ministry for University and Scientific and Technological Research</fundingAgency>
</fundingInfo>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without
<i>parkin</i>
mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the
<i>parkin</i>
mutation. Age at onset in carriers of
<i>parkin</i>
mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of
<i>parkin</i>
resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="fn1">
<p>Members of the French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease are listed in the
<link href="#app1">Appendix</link>
.</p>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>How much phenotypic variation can be attributed to parkin genotype?</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Phenotypic Variation of Parkin</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>How much phenotypic variation can be attributed to</title>
</titleInfo>
<name type="personal">
<namePart type="given">Ebba</namePart>
<namePart type="family">Lohmann</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Magali</namePart>
<namePart type="family">Periquet</namePart>
<namePart type="termsOfAddress">BS</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Vincenzo</namePart>
<namePart type="family">Bonifati</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Nick W.</namePart>
<namePart type="family">Wood</namePart>
<namePart type="termsOfAddress">MD, PhD, FRCP</namePart>
<affiliation>Department of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Giuseppe</namePart>
<namePart type="family">De Michele</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Dipartimento di Scienze Neurologiche, Università Federico II, Napoli, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Anne‐Marie</namePart>
<namePart type="family">Bonnet</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Valérie</namePart>
<namePart type="family">Fraix</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Emmanuel</namePart>
<namePart type="family">Broussolle</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Service de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Martin W. I. M.</namePart>
<namePart type="family">Horstink</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, University Medical Centre, Nijmegen, The Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Marie</namePart>
<namePart type="family">Vidailhet</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Service de Neurologie, Hôpital Saint Antoine, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Patrice</namePart>
<namePart type="family">Verpillat</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Département d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Thomas</namePart>
<namePart type="family">Gasser</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Neurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">David</namePart>
<namePart type="family">Nicholl</namePart>
<namePart type="termsOfAddress">MRCP</namePart>
<affiliation>Department of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Hélio</namePart>
<namePart type="family">Teive</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Movement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, Brazil</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Salmo</namePart>
<namePart type="family">Raskin</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Centro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, Brazil</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Olivier</namePart>
<namePart type="family">Rascol</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University Hospital</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alain</namePart>
<namePart type="family">Destée</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Université de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Merle</namePart>
<namePart type="family">Ruberg</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Francesca</namePart>
<namePart type="family">Gasparini</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Giuseppe</namePart>
<namePart type="family">Meco</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurological Sciences, “La Sapienza” University, Rome, Italy</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yves</namePart>
<namePart type="family">Agid</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alexandra</namePart>
<namePart type="family">Durr</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Alexis</namePart>
<namePart type="family">Brice</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM U289, Hôpital de la Salpêtrière, Paris, France</affiliation>
<affiliation>Fédération de Neurologie, Hôpital de la Salpêtrière, Paris</affiliation>
<affiliation>Département de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</affiliation>
<description>Correspondence: INSERM U289, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="corporate">
<namePart>The French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease</namePart>
<description>INSERM U289, Hôpital de la Salpêtrière, Paris, FranceDepartment of Neurological Sciences, “La Sapienza” University, Rome, ItalyDepartment of Clinical Neurology, Institute of Neurology and National Hospital for Neurology, London, United KingdomDipartimento di Scienze Neurologiche, Università Federico II, Napoli, ItalyFédération de Neurologie, Hôpital de la Salpêtrière, ParisDepartment of Clinical and Biological Neurosciences, Service de Neurologie, Centre Hospitalier Universitaire de Grenoble, FranceService de Neurologie, Hôpital Neurologique Pierre Wertheimer, Lyon Monchat, FranceDepartment of Neurology, University Medical Centre, Nijmegen, The NetherlandsService de Neurologie, Hôpital Saint Antoine, Paris, FranceDépartement d 'Epidémiologie, de Biostatistique et de Recherche Clinique, Hôpital Bichat‐Claude Bernard, Paris, FranceNeurologische Klinik Grosshadern, Ludwig‐Maximilians‐Universität, Münich, GermanyDepartment of Clinical Neurology, Queen Elizabeth Hospital, Birmingham, United KingdomMovement Disorders Unit, Neurology Service, Hospital de Clinicas, Federal University of Parana, BrazilCentro de Aconselhamento e Laboratorio Genetika, Alameda Augusto Stellfeld, Curitiba, Parana, BrazilDepartment of Clinical Pharmacology, Clinical Investigation Center, INSERM U455, Toulouse University HospitalUniversité de Lille II, Neurologie A, Clinique Neurologique, Hôpital Roger Salengro, Lille, FranceDépartement de Génétique, Cytogénétique et Embryologie, Hôpital de la Salpêtrière, Paris, France</description>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2003-08</dateIssued>
<dateCaptured encoding="w3cdtf">2002-11-22</dateCaptured>
<dateValid encoding="w3cdtf">2003-04-01</dateValid>
<copyrightDate encoding="w3cdtf">2003</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">1</extent>
<extent unit="tables">7</extent>
<extent unit="references">60</extent>
<extent unit="words">7585</extent>
</physicalDescription>
<abstract lang="en">To establish phenotype–genotype correlations in early‐onset parkinsonism, we have compared the phenotype of a large series of 146 patients with and 250 patients without parkin mutations. Although no single sign distinguished the groups, patients with mutations had significantly earlier and more symmetrical onset, dystonia more often at onset and hyperreflexia, slower progression of the disease, and a tendency toward a greater response to levodopa despite lower doses. After forward stepwise multiple logistic regression analysis, dystonia at onset and brisk reflexes were not longer significantly different but were correlated with age at onset rather than the presence of the parkin mutation. Age at onset in carriers of parkin mutations varied as did the rate of progression of the disease: the younger the age at onset the slower the evolution. The genotype influenced the phenotype: carriers of at least one missense mutation had a higher United Parkinson's Disease Rating Scale motor score than those carrying two truncating mutations. The localization of the mutations was also important because missense mutations in functional domains of parkin resulted in earlier onset. Patients with a single heterozygous mutation had significantly later and more asymmetrical onset and more frequent levodopa‐induced fluctuations and dystonia than patients with two mutations. Ann Neurol 2003</abstract>
<note type="funding">Association France‐Parkinson</note>
<note type="funding">European Community Biomed 2 - No. BMHCT960664; </note>
<note type="funding">AVENTIS‐PHARMA</note>
<note type="funding">National Institute of Health - No. NS41723‐01A1; </note>
<note type="funding">INSERM and Ministère de la Recherche - No. 4CH03G; </note>
<note type="funding">Italian Ministry for University and Scientific and Technological Research</note>
<relatedItem type="host">
<titleInfo>
<title>Annals of Neurology</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Ann Neurol.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<subject>
<genre>article category</genre>
<topic>Original Articles</topic>
</subject>
<identifier type="ISSN">0364-5134</identifier>
<identifier type="eISSN">1531-8249</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8249</identifier>
<identifier type="PublisherID">ANA</identifier>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>54</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>2</number>
</detail>
<extent unit="pages">
<start>176</start>
<end>185</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">8102A84AE65564CFF96B0DCEDB6A81510425F787</identifier>
<identifier type="DOI">10.1002/ana.10613</identifier>
<identifier type="ArticleID">ANA10613</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2003 American Neurological Association</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E78 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E78 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:8102A84AE65564CFF96B0DCEDB6A81510425F787
   |texte=   How much phenotypic variation can be attributed to parkin genotype?
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024